XML 52 R39.htm IDEA: XBRL DOCUMENT v3.19.2
Revenue - Summary of Revenues Disaggregated by Product Classification and Operating Segment (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Disaggregation Of Revenue [Line Items]        
Total revenue $ 24,344 $ 22,227 $ 69,261 $ 58,298
Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 9,870 10,475 29,508 27,249
Royalties [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 11,624 9,597 31,652 25,101
Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 2,850 2,155 8,101 5,948
Operating Segments [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 24,344 22,227 69,261 58,298
Operating Segments [Member] | Medical Device [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 18,945 16,701 53,504 43,527
Operating Segments [Member] | Medical Device [Member] | Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 4,500 4,958 13,836 12,495
Operating Segments [Member] | Medical Device [Member] | Royalties [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 9,605 7,730 25,603 22,663
Operating Segments [Member] | Medical Device [Member] | Research, Development and Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 2,821 2,146 8,016 5,931
Operating Segments [Member] | Medical Device [Member] | License Fees [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 2,019 1,867 6,049 2,438
Operating Segments [Member] | In Vitro Diagnostics [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 5,399 5,526 15,757 14,771
Operating Segments [Member] | In Vitro Diagnostics [Member] | Product Sales [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue 5,370 5,517 15,672 14,754
Operating Segments [Member] | In Vitro Diagnostics [Member] | Other [Member]        
Disaggregation Of Revenue [Line Items]        
Total revenue $ 29 $ 9 $ 85 $ 17